Published in J Control Release on May 01, 2007
Applications of orthogonal "click" chemistries in the synthesis of functional soft materials. Chem Rev (2009) 2.28
Polymeric micelles in anticancer therapy: targeting, imaging and triggered release. Pharm Res (2010) 1.83
Enzyme-triggered disassembly of dendrimer-based amphiphilic nanocontainers. J Am Chem Soc (2009) 1.23
Polymersome carriers: from self-assembly to siRNA and protein therapeutics. Eur J Pharm Biopharm (2008) 1.21
Physicochemical characteristics of pH-sensitive poly(L-histidine)-b-poly(ethylene glycol)/poly(L-lactide)-b-poly(ethylene glycol) mixed micelles. J Control Release (2007) 1.18
Controlling and switching the morphology of micellar nanoparticles with enzymes. J Am Chem Soc (2011) 1.11
Lysosomal delivery of a lipophilic gemcitabine prodrug using novel acid-sensitive micelles improved its antitumor activity. Bioconjug Chem (2012) 1.00
Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution. Nano Lett (2012) 0.93
Poly(PS-b-DMA) micelles for reactive oxygen species triggered drug release. J Control Release (2012) 0.93
Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. J Drug Deliv (2013) 0.93
Guest-release control in enzyme-sensitive, amphiphilic-dendrimer-based nanoparticles through photochemical crosslinking. Chemistry (2011) 0.92
Fabrication and intracellular delivery of doxorubicin/carbonate apatite nanocomposites: effect on growth retardation of established colon tumor. PLoS One (2013) 0.88
Extracellular vesicles and their synthetic analogues in aging and age-associated brain diseases. Biogerontology (2014) 0.87
Specific tumor delivery of paclitaxel using glycolipid-like polymer micelles containing gold nanospheres. Biomaterials (2013) 0.83
Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations. Int J Nanomedicine (2011) 0.83
The pH-induced thermosensitive poly (NIPAAm-co-AAc-co-HEMA)-g-PCL micelles used as a drug carrier. J Mater Sci Mater Med (2010) 0.82
Bioavailability of phytochemicals and its enhancement by drug delivery systems. Cancer Lett (2013) 0.81
Accessing lipophilic ligands in dendrimer-based amphiphilic supramolecular assemblies for protein-induced disassembly. Chemistry (2011) 0.80
Photocytotoxicity of mTHPC (temoporfin) loaded polymeric micelles mediated by lipase catalyzed degradation. Pharm Res (2008) 0.80
Influence of backbone conformational rigidity in temperature-sensitive amphiphilic supramolecular assemblies. J Am Chem Soc (2015) 0.79
Redox, Ionic Strength, and pH Sensitive Supramolecular Polymer Assemblies. J Polym Sci A Polym Chem (2009) 0.79
Controlled drug release to cancer cells from modular one-photon visible light-responsive micellar system. Chem Commun (Camb) (2016) 0.77
Multifunctional nanoassemblies of block copolymers for future cancer therapy. Sci Technol Adv Mater (2010) 0.77
Redox-sensitive nanoparticles from amphiphilic cholesterol-based block copolymers for enhanced tumor intracellular release of doxorubicin. Nanomedicine (2015) 0.76
Intraocular Implants for the Treatment of Autoimmune Uveitis. J Funct Biomater (2015) 0.76
Nanogels as potential nanomedicine carrier for treatment of cancer: A mini review of the state of the art. Saudi Pharm J (2014) 0.76
Impact of core-forming segment structure on drug loading in biodegradable polymeric micelles using PEG-b-poly(lactide-co-depsipeptide) block copolymers. Biomed Res Int (2014) 0.75
Nanoencapsulation for drug delivery. EXCLI J (2014) 0.75
Assessment of palmitoyl and sulphate conjugated glycol chitosan for development of polymeric micelles. Bioimpacts (2013) 0.75
Glutathione-responsive nano-transporter-mediated siRNA delivery: silencing the mRNA expression of Ras. Protoplasma (2012) 0.75
Synthesis, physiochemical characterization, and in vitro antitumor activity of the amide and pH cleavable hydrazone conjugates of γ-tocotrienol isomer of vitamin E with methoxy-poly(ethylene) glycol. Int J Pharm (2017) 0.75
Protein instability in poly(lactic-co-glycolic acid) microparticles. Pharm Res (2000) 2.17
Novel crosslinking methods to design hydrogels. Adv Drug Deliv Rev (2002) 2.11
Cationic polymer based gene delivery systems. Pharm Res (2000) 1.98
Tumour-targeted nanomedicines: principles and practice. Br J Cancer (2008) 1.81
Cellular uptake of cationic polymer-DNA complexes via caveolae plays a pivotal role in gene transfection in COS-7 cells. Pharm Res (2007) 1.39
Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br J Cancer (2008) 1.23
Structure-activity relationships of water-soluble cationic methacrylate/methacrylamide polymers for nonviral gene delivery. Bioconjug Chem (1999) 1.22
The effect of a water/organic solvent interface on the structural stability of lysozyme. J Control Release (2000) 1.14
Steric stabilization of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes mediates prolonged circulation and tumor targeting in mice. J Gene Med (2004) 1.10
Physically crosslinked dextran hydrogels by stereocomplex formation of lactic acid oligomers: degradation and protein release behavior. J Control Release (2001) 1.09
Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem (2002) 1.07
Thermosensitive polymers as carriers for DNA delivery. J Control Release (1999) 1.04
2-(Dimethylamino)ethyl methacrylate based (co)polymers as gene transfer agents. J Control Release (1998) 1.04
Effect of DNA topology on the transfection efficiency of poly((2-dimethylamino)ethyl methacrylate)-plasmid complexes. J Control Release (1999) 1.03
Effect of size and serum proteins on transfection efficiency of poly ((2-dimethylamino)ethyl methacrylate)-plasmid nanoparticles. Pharm Res (1996) 1.01
Controlled release of a model protein from enzymatically degrading dextran microspheres. J Control Release (1999) 1.00
In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts. Biomaterials (2001) 0.99
An NLS peptide covalently linked to linear DNA does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Gene Med (2005) 0.98
Photopolymerized thermosensitive hydrogels for tailorable diffusion-controlled protein delivery. J Control Release (2009) 0.98
Influence of neutron irradiation on holmium acetylacetonate loaded poly(L-lactic acid) microspheres. Biomaterials (2002) 0.98
Production of GMP-grade radioactive holmium loaded poly(L-lactic acid) microspheres for clinical application. Int J Pharm (2006) 0.97
The fate of poly(2-dimethyl amino ethyl)methacrylate-based polyplexes after intravenous administration. Int J Pharm (2001) 0.97
Micelles based on HPMA copolymers. Adv Drug Deliv Rev (2009) 0.96
The effect of the processing and formulation parameters on the size of nanoparticles based on block copolymers of poly(ethylene glycol) and poly(N-isopropylacrylamide) with and without hydrolytically sensitive groups. Biomaterials (2004) 0.93
Degradation kinetics of methacrylated dextrans in aqueous solution. J Pharm Sci (1997) 0.92
Effect of molecular weight and glass transition on relaxation and release behaviour of poly(DL-lactic acid) tablets. J Control Release (2001) 0.92
Lysozyme distribution and conformation in a biodegradable polymer matrix as determined by FTIR techniques. J Control Release (2000) 0.92
Preparation and characterization of folate-targeted pEG-coated pDMAEMA-based polyplexes. J Control Release (2003) 0.91
Characterization of poly(L-lactic acid) microspheres loaded with holmium acetylacetonate. Biomaterials (2001) 0.90
Water-soluble biodegradable cationic polyphosphazenes for gene delivery. J Control Release (2003) 0.89
Neutron activation of holmium poly(L-lactic acid) microspheres for hepatic arterial radio-embolization: a validation study. Biomed Microdevices (2009) 0.88
Drug targeting to the kidney: Advances in the active targeting of therapeutics to proximal tubular cells. Adv Drug Deliv Rev (2010) 0.88
The use of aqueous PEG/dextran phase separation for the preparation of dextran microspheres. Int J Pharm (1999) 0.87
Degradable dextran hydrogels: controlled release of a model protein from cylinders and microspheres. J Control Release (1999) 0.86
Fourier transform infrared spectrometric analysis of protein conformation: effect of sampling method and stress factors. Anal Biochem (2001) 0.86
Microspheres with ultrahigh holmium content for radioablation of malignancies. Pharm Res (2009) 0.85
Removal of chloroform from biodegradable therapeutic microspheres by radiolysis. Int J Pharm (2006) 0.85
Preparation and characterization of protein loaded microspheres based on a hydroxylated aliphatic polyester, poly(lactic-co-hydroxymethyl glycolic acid). J Control Release (2009) 0.85
Lipid-coated polyplexes for targeted gene delivery to ovarian carcinoma cells. Cancer Gene Ther (2001) 0.84
The preparation of dextran microspheres in an all-aqueous system: effect of the formulation parameters on particle characteristics. Pharm Res (1998) 0.84
Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization. J Drug Target (2000) 0.83
In vivo biocompatibility of dextran-based hydrogels. J Biomed Mater Res (2000) 0.83
Degradable PEG-folate coated poly(DMAEA-co-BA)phosphazene-based polyplexes exhibit receptor-specific gene expression. Eur J Pharm Sci (2007) 0.83
Renal targeting of kinase inhibitors. Int J Pharm (2008) 0.83
Covalent attachment of an NLS-peptide to linear dna does not enhance transfection efficiency of cationic polymer based gene delivery systems. J Control Release (2005) 0.82
Association and dissociation characteristics of polymer/DNA complexes used for gene delivery. Pharm Res (1999) 0.82
Mechanistic studies on the degradation and protein release characteristics of poly(lactic-co-glycolic-co-hydroxymethylglycolic acid) nanospheres. Biomacromolecules (2013) 0.82
The downmodulation of the foreign body reaction by cytomegalovirus encoded interleukin-10. Biomaterials (2008) 0.82
The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles. J Control Release (2013) 0.82
Stabilization of polymer-based gene delivery systems. Int J Pharm (1999) 0.81
Targeted core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin. J Control Release (2010) 0.81
The VX2 carcinoma in the rabbit auricle as an experimental model for intra-arterial embolization of head and neck squamous cell carcinoma with dextran microspheres. Lab Anim (1999) 0.81
Imatinib-ULS-lysozyme: a proximal tubular cell-targeted conjugate of imatinib for the treatment of renal diseases. J Control Release (2011) 0.81
A comparative biocompatibility study of microspheres based on crosslinked dextran or poly(lactic-co-glycolic)acid after subcutaneous injection in rats. J Biomed Mater Res (2001) 0.80
Biodegradable hydrogels based on stereocomplex formation between lactic acid oligomers grafted to dextran. J Control Release (2001) 0.80
Pore sizes in hydrated dextran microspheres. Biomacromolecules (2000) 0.80
An in vitro study of the adhesion of blood platelets onto vascular catheters. Part I. J Biomed Mater Res (1987) 0.80
Synthesis and characterization of biodegradable and thermosensitive polymeric micelles with covalently bound doxorubicin-glucuronide prodrug via click chemistry. Bioconjug Chem (2011) 0.80
Hydrogels of collagen-inspired telechelic triblock copolymers for the sustained release of proteins. J Control Release (2010) 0.80
Surface characteristics of holmium-loaded poly(L-lactic acid) microspheres. Biomaterials (2005) 0.80
Interaction of albumin-heparin conjugate preadsorbed surfaces with blood. Trans Am Soc Artif Intern Organs (1983) 0.80
Antitumor efficacy of dexamethasone-loaded core-crosslinked polymeric micelles. J Control Release (2012) 0.80
Characterization of holmium loaded alginate microspheres for multimodality imaging and therapeutic applications. J Biomed Mater Res A (2007) 0.80
Degradable dextran microspheres for the controlled release of liposomes. Int J Pharm (2001) 0.79
Local low-dose IL-2 therapy. Hepatogastroenterology (1999) 0.79
Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation. Pharm Res (2007) 0.79
Preparation and characterization of poly(lactic-co-glycolic acid) microspheres loaded with a labile antiparkinson prodrug. Int J Pharm (2011) 0.79
Biodegradable dextran hydrogels crosslinked by stereocomplex formation for the controlled release of pharmaceutical proteins. Int J Pharm (2004) 0.79
Comparative transfection studies of human ovarian carcinoma cells in vitro, ex vivo and in vivo with poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes. J Gene Med (2000) 0.79
Effect of excipients on the encapsulation efficiency and release of human growth hormone from dextran microspheres. Eur J Pharm Biopharm (2007) 0.79
Microspheres of hydrophilic PLGA highly attractive for protein delivery. J Control Release (2010) 0.79
Effective cancer therapy with a single injection of interleukin-2 at the site of the tumour. Cancer Immunol Immunother (1999) 0.78
A versatile method for the conjugation of proteins and peptides to poly[2-(dimethylamino)ethyl methacrylate]. Bioconjug Chem (1999) 0.78
Lanthanide bearing microparticulate systems for multi-modality imaging and targeted therapy of cancer. Curr Med Chem Anticancer Agents (2005) 0.78
Controlled release of liposomes from biodegradable dextran microspheres: a novel delivery concept. Pharm Res (2000) 0.78
In-situ forming hydrogels by simultaneous thermal gelling and Michael addition reaction between methacrylate bearing thermosensitive triblock copolymers and thiolated hyaluronan. J Control Release (2010) 0.78
Cationic polymeric gene delivery of beta-glucuronidase for doxorubicin prodrug therapy. J Gene Med (2000) 0.78
Flow cytometry for rapid size determination and sorting of nucleic acid containing nanoparticles in biological fluids. J Control Release (2009) 0.78
Biodegradable microspheres loaded with an anti-Parkinson prodrug: an in vivo pharmacokinetic study. Mol Pharm (2011) 0.78
Fluorescence in situ hybridization to monitor the intracellular location and accessibility of plasmid DNA delivered by cationic polymer-based gene carriers. Eur J Pharm Biopharm (2008) 0.78
Release of recombinant human interleukin-2 from dextran-based hydrogels. J Control Release (2002) 0.77
IL-2 loaded dextran microspheres with attractive histocompatibility properties for local IL-2 cancer therapy. Cytokine (2003) 0.77
The influence of bile acids on the oral bioavailability of vitamin K encapsulated in polymeric micelles. J Control Release (2008) 0.77
Long term stability of poly((2-dimethylamino)ethyl methacrylate)-based gene delivery systems. Pharm Res (1999) 0.77
Sterilization of poly(dimethylamino) ethyl methacrylate-based gene transfer complexes. Int J Pharm (2000) 0.77
Formation of dextran hydrogels by crystallization. Biomaterials (2001) 0.77